Table 2 Causes of death among HIV-infected women followed in the MTCT-Plus program and treated with NVP-based HAART.
# | CD4 count* cells/mm 3 | Pregnancy at HAART initiation | Regimen* | Cause of death | Time of death** (months) | History of SAEs | Description of SAEs | Time of occurrence of SAEs** (months) |
|---|---|---|---|---|---|---|---|---|
1 | 253 | No | AZT/3TC/NVP | Mulitple myeloma | 26.7 | Yes | Neutropenia grade 3 | 7.2 |
2 | 241 | No | AZT/3TC/NVP | Hepatitis B | 24.6 | Yes | Hepatotoxicity grade 3 | 24.2 |
3 | 332 | No | AZT/3TC/NVP | Hepatitis B | 13.3 | Yes | Anaemia grade 4 | 1.2 |
4 | 230 | No | AZT/3TC/NVP | Unknown | 24.9 | Yes | Neutropenia grade 4 | 9.2 |
5 | 271 | Yes | AZT/3TC/NVP | Severe anaemia | 3.7 | Yes | Anaemia grade 4 | 3.4 |
6 | 250 | No | AZT/3TC/NVP | AIDS terminal | 14.0 | Yes | Neutropenia Grade3 | 4.6 |
7 | 193 | No | AZT/3TC/NVP | Cerebral malaria | 20.8 | Yes | Rash grade 3 | 0.7 |
8 | 39 | Yes | AZT/3TC/NVP | AIDS terminal | 10.6 | Yes | Rash grade 3 | 2.0 |
9 | 170 | Yes | AZT/3TC/NVP | AIDS terminal | 20.4 | No | ||
10 | 186 | Yes | d4T/3TC/NVP | Eclampsia | 1.8 | No | ||
11 | 7 | No | AZT/3TC/NVP | Pneumonia | 6.9 | No | ||
12 | 226 | No | d4T/3TC/NVP | Renal tumor | 2.0 | No | ||
13 | 121 | No | AZT/3TC/NVP | Cerebral malaria | 10.0 | No | ||
14 | 84 | Yes | AZT/3TC/NVP | Fever | 9.8 | No | ||
15 | 24 | No | AZT/3TC/NVP | Meningitis | 7.4 | No | ||
16 | 288 | Yes | AZT/3TC/NVP | Gastric perforation | 12.9 | No |